JVLIX
Price
$22.73
Change
-$0.07 (-0.31%)
Updated
May 22 closing price
Net Assets
17.15B
VIVAX
Price
$66.01
Change
-$0.28 (-0.42%)
Updated
May 22 closing price
Net Assets
183.65B
Interact to see
Advertisement

JVLIX vs VIVAX

Header iconJVLIX vs VIVAX Comparison
Open Charts JVLIX vs VIVAXBanner chart's image
JHancock Disciplined Value I
Price$22.73
Change-$0.07 (-0.31%)
VolumeN/A
Net Assets17.15B
Vanguard Value Index I
Price$66.01
Change-$0.28 (-0.42%)
VolumeN/A
Net Assets183.65B
JVLIX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JVLIX vs. VIVAX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVLIX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 184B vs. JVLIX (17.1B). VIVAX pays higher dividends than JVLIX: VIVAX (2.22) vs JVLIX (1.02). JVLIX was incepted earlier than VIVAX: JVLIX (28 years) vs VIVAX (33 years). JVLIX (0.72) is less costly to investors than VIVAX (0.17). JVLIX is a more actively managed with annual turnover of: 48.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than JVLIX: VIVAX (3000) vs JVLIX (250000). VIVAX annual gain was more profitable for investors over the last year : 4.71 vs. JVLIX (-6.46). VIVAX return over 5 years is better than : 75.18 vs. JVLIX (43.03).
JVLIXVIVAXJVLIX / VIVAX
Total Expense Ratio0.710.17418%
Annual Report Gross Expense Ratio0.720.17424%
Fund Existence28 years33 years-
Gain YTD1.5590.375416%
Front LoadN/AN/A-
Min. Initial Investment25000030008,333%
Min. Initial Investment IRAN/AN/A-
Net Assets17.1B184B9%
Annual Yield % from dividends1.022.2246%
Returns for 1 year-6.464.71-137%
Returns for 3 years4.1321.9719%
Returns for 5 years43.0375.1857%
Returns for 10 years24.5397.3525%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQH52.130.29
+0.56%
Equitable Holdings
TGNA16.74N/A
N/A
TEGNA
FLGT20.28N/A
N/A
Fulgent Genetics
OFS8.29-0.15
-1.78%
OFS Capital Corp
ENSC2.17-0.06
-2.91%
Ensysce Biosciences